$93.35
arrow_drop_up3.66%Key Stats | |
---|---|
Open | $87.72 |
Prev. Close | $87.56 |
EPS | -6.58 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 85.08 | 88.25 |
52 Week Range | 55.02 | 98.40 |
Ratios | |
---|---|
EPS | -6.58 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
1 Under-the-Radar Biotech Stock to Buy and Hold
FDA Accepts AXSM's NDA Resubmission for Migraine Drug, Stock Up
Axsome Therapeutics Announces FDA Acceptance of NDA Resubmission for AXS-07 for the Acute Treatment of Migraine
Should You Buy This Sinking Stock on the Dip?
Intra-Cellular's (ITCI) Caplyta Boosts Sales, Dependence a Woe
Why Axsome Therapeutics Stock Is Sinking Today